The study observed obesity and body weight as the significant cause behind early joint damage. Here’s what you need to know.

A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay the need for knee replacements, results of a study have revealed. Researchers from ...

BOSTON (AP) — Boston Red Sox first baseman Triston Casas suffered a ruptured tendon in his left knee and is out for the remainder of the season, the team said. The 25-year-old Casas ruptured his ...

For patients with overweight or obesity and symptomatic knee osteoarthritis, the researchers found that the mean change in VAS pain was −31.3 and −18.9 mm in the metformin and placebo groups ...

Metformin may improve knee pain in patients with knee osteoarthritis and overweight or obesity. HealthDay News — For patients with overweight or obesity and symptomatic knee osteoarthritis ...

THURSDAY, May 1, 2025 (HealthDay News) — For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo, ...

T HURSDAY, May 1, 2025 (HealthDay News) -- For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo ...

INCHEON, South Korea — The diabetes drug metformin may reduce the pain of knee osteoarthritis (OA) in patients with overweight or obese, independent of weight loss, according to results from a ...

Because of its complex range of motion and the weight that’s often distributed through the joint, the knee is vulnerable to injury. The knee is one of the most complex joints in your body.

Simply sign up to the Style myFT Digest -- delivered directly to your inbox. I have been seeing a lot of knee-length skirts in shops and on social media. Are they back in style? Do I need to take ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug ...